Pituitary & hypothalamus

Diurnal Range and Intra-patient Variability of ACTH Is Restored With Remission in Cushing's Disease

J Clin Endocrinol MetabPublished Retrospective cohort study

Authors' conclusion

Our findings suggest that ACTH variability is suppressed in CD, and remission from CD is associated with the restoration of this variability. Furthermore, a decrease in plasma ACTH by 50% or more may serve as a predictor of remission post-TSS. These insights could guide clinicians in developing rational outcome measures for interventions targeting CD adenomas.

Study context

Population
Cushing's disease (CD) patients with ACTH measurements before and after transsphenoidal surgery (TSS), 2005–2019, referral center
Participants
253 patients
Exposure
Remission vs nonremission after TSS
  • Remissionn = 223
Outcome
Remission after TSS
Methodological detailssingle referral centre
  • Single referral centre

Main finding

As reported in the abstract

Remission

223

events

Observational data: associations, not effects.

Further findings

OutcomeP value
ACTH variability · AM and PMRemission vs Nonremission · higher with remissionP = 0.02
ACTH variability · AM and PMRemission vs Nonremission · higher with remissionP < 0.001
ACTH diurnal rangeSignificantly narrower with nonremissionP = <.0001

Predictors of remission/nonremission

Absolute plasma ACTH concentration associated with nonremission (multivariable logistic regression)
adj P < .001
Ratio of preoperative to postoperative ACTH associated with nonremission (multivariable logistic regression)
adj P .001
Decrease in plasma ACTH ≥50% from mean preoperative levels predicted CD remission after TSS, especially with PM values

Original publication

Diurnal Range and Intra-patient Variability of ACTH Is Restored With Remission in Cushing's Disease. J Clin Endocrinol Metab. Published 1 June 2023. doi:10.1210/clinem/dgad309

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.